Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04151498 · ClinicalTrials.gov registry record · NA

HIV Reengagement and Assessment Mobile Program (Project RAMP)

A NA study of HIV/AIDS, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT04151498: Completed NA study of HIV/AIDS, sponsored by University of North Carolina, Chapel Hill.

NCT04151498 is a NA study of HIV/AIDS that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 30 participants, below the 33,180-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04151498, a NA study of HIV/AIDS, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The North Carolina Bridge Counselor system is designed to help link out of care HIV positive patients back into HIV care. It has improved initial linkages and patient re-engagement overall, but for a sizable group of patients, the current system has not been effective, leaving a population of hard-to-reach, lost-to-care patients who remain out of care. There is limited understanding of the lived experiences of patients who fall out of HIV care and become recalcitrant to re-engagement because they are difficult to reach and therefore underrepresented in research. Out of care HIV+ patients who have not reengaged in care following the standard of care who chose to enroll in the study will participate in 2 semi-structured interviews and receive a field-based HIV re-engagement and treatment intervention (Project RAMP). Project RAMP will consist of up to 4 visits from an outreach research nurse designed to serve as an "on-ramp" to HIV care. At these visits, the outreach number will counsel on HIV care and treatment and obtain a medical history and labs. Results will be communicated to the participant's clinic provider in an effort to both encourage the patient to return to care and facilitate more rapid antiretroviral therapy (ART) initiation by the clinic provider. The research team will also provide the participant in-person assistance with scheduling a clinic visit. Clinic providers may re-initiate ART prior to the reengagement clinic visit, with adherence support provided by the outreach nurse.

Primary Outcome

Percentage of all eligible persons that are screened by the study team that enroll in Project RAMP during the intervention period.

Conditions Studied

Interventions

  • OTHER Qualitative Interview
  • BEHAVIORAL Reengagement and Assessment Mobile Program

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2020-05-29
Est. Completion 2023-04-28
Phase NA

What the finished NCT04151498 record still lists

NCT04151498 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 33,180-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower).

The record links to 1 condition, with HIV/AIDS appearing as the primary indexed condition, and to 2 interventions - of which Qualitative Interview is the first listed.

NCT04151498 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT04151498 about?

NCT04151498 is a clinical study titled "HIV Reengagement and Assessment Mobile Program (Project RAMP)". The North Carolina Bridge Counselor system is designed to help link out of care HIV positive patients back into HIV care. It has improved initial linkages and patient re-engagement overall, but for a sizable group of patients, the current system has not been effective, leaving a population of hard-t...

What is the current status of trial NCT04151498?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2020-05-29. Estimated completion is 2023-04-28.

What conditions does trial NCT04151498 study?

This clinical trial studies the following conditions: HIV/AIDS.

What interventions are being tested in trial NCT04151498?

The interventions under investigation include: Qualitative Interview (OTHER), Reengagement and Assessment Mobile Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT04151498?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04151498 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV/AIDS

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04151498's enrollment target sits among peer trials

30 52nd of 61 higher than 9 of 61 other HIV/AIDS trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV/AIDS trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04151498, the US trial registry maintained by the National Library of Medicine. NCT04151498 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.